Avoid common mistakes on your manuscript.
Poliovirus 1 (PV1), a member of the species Enterovirus C, causes poliomyelitis and has almost been eradicated globally following world-wide vaccination campaigns since the 1960s. Yet, rare fatal cases due to infections with wild-type PV1 or circulating vaccine-derived poliovirus are still being reported in some developing countries [6, 7]. PV1 is among the bests studied RNA viruses; however, PV1 genomes have been sequenced mostly from feces samples or after passage in cell culture and to our knowledge never from nervous tissue directly. Thus, we know little about the genetic diversity of neurovirulent wild-type strains in the CNS of affected patients in the pre-vaccination era.
Through archive mining, we retrieved paraffin-embedded autopsy brain samples and related medical records of a neonate (patient #1) and an adult (patient #2) diagnosed with poliomyelitis from the early 1950s, before poliovirus vaccines were available (Table 1). Both patients presented progressive neurological signs and died despite attempts of negative pressure ventilation. The autopsy tissues had been submitted to our division by a hospital in Switzerland for neuropathological assessment and showed a severe polioencephalomyelitis (patient #1), and poliomyelitis (patient #2) (Table 1). The lesions were more severe in the neonate than in the adult, and there were differences in the histopathological lesion pattern, which were consistent with reports in the literature [1, 5]. Lesions in patient #1 consisted of a marked infiltration of phagocytotic cells (microglia, macrophages, and neutrophils), while lesions in patient#2 involved almost exclusively microglia/macrophages (Fig. 1a–e, Supplementary Fig. 1 a–f and Supplementary Table 2—online resources).
To demonstrate infection with PV1 and to obtain genetic virus information, we extracted RNA from CNS tissues of both patients and submitted it to high-throughput sequencing followed by bioinformatics analysis (Supplementary methods—online resource). We obtained two, coding-complete PV1 genome sequences, which we designated strains CHE2132/54 (patient #1; GenBank OP828753.1) and CHE1884/53 (patient #2; GenBank OP828752.1).
Based on the new PV1 sequences, we designed a probe for RNA in situ hybridization (Supplementary methods—online resource), and demonstrated viral genomic RNA within CNS tissue in both patients (Fig. 1h–j), confirming that they were affected by PV1 poliomyelitis.
For strain CHE2132/54, only 3 nucleotides (nt), and for CHE1884/53, 432 nt are missing at the genome 5′ end in the untranslated region (UTR) when compared to the PV1 reference strain (Mahoney; GenBank V01148.1).
Both strains showed a sequence similarity of 91% to each other but less than 83% compared to other PV1 strains (Supplementary Table 3—online resource). Phylogenetic analysis corroborates this finding and shows that both strains cluster together but are clearly distinct from previously reported PV1 strains (Fig. 2). Conversely, the encoded polyprotein sequences are highly conserved with > 97% identity compared to other PV1 strains, indicating a high selection pressure (Supplementary Table 3—online resource). Of particular note is that both new sequences showed genomic key features of neurovirulent PV1 strains, e.g., an adenine residue at position 480 of the 5′-untranslated region (UTR), which contribute to neurovirulence in the Mahoney strain [3] (Supplementary Fig. 3—online resource).
In conclusion, by sequencing almost full genomes of PV1 in 70-year-old archived paraffin-embedded CNS tissues, we found substantial genetic divergence from previously described PV1 strain genomes. Whether this divergence reflects viral adaptions to the nervous tissue or indicates particular PV1 strains that circulated in the middle of the twentieth century in Europe will need to be subject of continued research.
Data availability
High-throughput sequencing data are available at the sequence read archive of the national center for biotechnology information, Bioproject PRJNA899910 (https://www.ncbi.nlm.nih.gov/sra/PRJNA899910). Poliovirus 1 sequences are available at ncbi GenBank with accession number OP828752 (patient #2) and OP828753 (patient #1).
References
Greenfield JG (2002) Greenfield’s neuropathology. In: Graham DI, Lantos PL (eds) Viral diseases, 7th edn. Arnold, London, pp 10–15
Katoh K, Misawa K, Kuma KI, Miyata T (2002) MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30:3059–3066. https://doi.org/10.1093/NAR/GKF436
Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M et al (1989) Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol 63:1302–1309. https://doi.org/10.1128/jvi.63.3.1302-1309.1989
Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35:1547–1549. https://doi.org/10.1093/molbev/msy096
Pugh RCB, Dudgeon JA (1954) Fatal neonatal poliomyelitis. Arch Dis Child 29:381–384. https://doi.org/10.1136/adc.29.147.381
Circulating vaccine-derived poliovirus—GPEI. https://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/. Accessed 14 May 2022
Polio Now—GPEI. https://polioeradication.org/polio-today/polio-now/. Accessed 14 May 2022
Acknowledgements
We thank Elsbeth Keller-Gautschi and Laurine Sendra for excellent technical support as well as the Next Generation Sequencing Platform of the University of Bern for performing the high-throughput sequencing experiments. We also thank Camille Monney for performing the IHC staining.
Funding
Open access funding provided by University of Bern. This research was supported by the Swiss Federal Food Safety and Veterinary Office.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval for retrospective studies
The study does not need any ethics approval according to the law and the national ethical guidelines of Switzerland.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wildi, N., Bagatella, S., Koch, M.C. et al. Archival wild-type poliovirus 1 infected central nervous system tissues of the pre-vaccination era in Switzerland reveal a distinct virus genotype. Acta Neuropathol 145, 357–359 (2023). https://doi.org/10.1007/s00401-023-02545-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-023-02545-5